Correlation Between Viking Therapeutics and Codiak BioSciences
Can any of the company-specific risk be diversified away by investing in both Viking Therapeutics and Codiak BioSciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viking Therapeutics and Codiak BioSciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viking Therapeutics and Codiak BioSciences, you can compare the effects of market volatilities on Viking Therapeutics and Codiak BioSciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viking Therapeutics with a short position of Codiak BioSciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viking Therapeutics and Codiak BioSciences.
Diversification Opportunities for Viking Therapeutics and Codiak BioSciences
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Viking and Codiak is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Viking Therapeutics and Codiak BioSciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Codiak BioSciences and Viking Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viking Therapeutics are associated (or correlated) with Codiak BioSciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Codiak BioSciences has no effect on the direction of Viking Therapeutics i.e., Viking Therapeutics and Codiak BioSciences go up and down completely randomly.
Pair Corralation between Viking Therapeutics and Codiak BioSciences
If you would invest (100.00) in Codiak BioSciences on November 9, 2024 and sell it today you would earn a total of 100.00 from holding Codiak BioSciences or generate -100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Viking Therapeutics vs. Codiak BioSciences
Performance |
| Timeline |
| Viking Therapeutics |
| Codiak BioSciences |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Viking Therapeutics and Codiak BioSciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viking Therapeutics and Codiak BioSciences
The main advantage of trading using opposite Viking Therapeutics and Codiak BioSciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viking Therapeutics position performs unexpectedly, Codiak BioSciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Codiak BioSciences will offset losses from the drop in Codiak BioSciences' long position.| Viking Therapeutics vs. Terns Pharmaceuticals | Viking Therapeutics vs. Akero Therapeutics | Viking Therapeutics vs. Madrigal Pharmaceuticals | Viking Therapeutics vs. Sarepta Therapeutics |
| Codiak BioSciences vs. Lowes Companies | Codiak BioSciences vs. Federal Home Loan | Codiak BioSciences vs. Bassett Furniture Industries | Codiak BioSciences vs. Transcontinental Realty Investors |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| CEOs Directory Screen CEOs from public companies around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |